GDRX

GoodRx Holdings, Inc. Class A Common Stock

2.69

USD

GDRX Earnings Reports

Positive Surprise Ratio

GDRX beat 12 of 21 last estimates.

57%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$196.68M

$0.09

Implied change from Q3 25 (Revenue/ EPS)

+0.33%

+12.50%

Implied change from Q4 24 (Revenue/ EPS)

-0.96%

GoodRx Holdings, Inc. Class A Common Stock earnings per share and revenue

On Nov 04, 2025, GDRX reported earnings of 0.08 USD per share (EPS) for Q3 25, missing the estimate of 0.09 USD, resulting in a -13.42% surprise. Revenue reached 196.03 million, compared to an expected 198.44 million, with a -1.22% difference. The market reacted with a +2.15% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 16 analysts forecast an EPS of 0.09 USD, with revenue projected to reach 196.68 million USD, implying an increase of 12.50% EPS, and increase of 0.33% in Revenue from the last quarter.

FAQ

What were GoodRx Holdings, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, GoodRx Holdings, Inc. Class A Common Stock reported EPS of $0.08, missing estimates by -13.42%, and revenue of $196.03M, -1.22% below expectations.

How did the market react to GoodRx Holdings, Inc. Class A Common Stock's Q3 2025 earnings?

The stock price moved up 2.15%, changed from $3.26 before the earnings release to $3.33 the day after.

When is GoodRx Holdings, Inc. Class A Common Stock expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for GoodRx Holdings, Inc. Class A Common Stock's next earnings report?

Based on 16 analysts, GoodRx Holdings, Inc. Class A Common Stock is expected to report EPS of $0.09 and revenue of $196.68M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.